HumanexaHumanexaHumanexa
WelcomeSignalsCompaniesAssetsScenario AnalysisRegulatoryStrategy
InsightsNewslettersReportsBriefings
Pricing
WorkspaceTeamWatchlistsCollectionsSettings

Free

Intelligence Active

Regunera

FDA

Regulatory intelligence
FDAsafety guidance72% confidence

Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products

Source: FDA

Why This Matters

Why this matters: sets a safety guidance precedent in the same sub-indication (pain) as pediatric anesthesia practices.

Regulatory Analysis

Supporting Context

Therapeutic area
Anesthesiology · Pediatric Pain Management
Sub-indication
Pain

Related signal: Study on Perfusion Index vs Surgical Pleth Index for Pediatric Caudal Block Effectiveness

Source

View source document

Related Signal

Open signal — Study on Perfusion Index vs Surgical Pleth Index for Pediatric Caudal Block Effectiveness
PrivacyTermsRefund PolicyDisclaimerContact

© 2026 Humanexa. Intelligence for research workflows — not medical, legal, regulatory filing, or investment advice.